Barclays Adjusts Price Target on Kimberly-Clark to $105 From $115, Keeps Equalweight Rating
Barclays lowered its price target on Kimberly-Clark (KMB) from $115 to $105, maintaining an equalweight rating. The company is reportedly considering asset sales to secure EU approval for its Kenvue acquisition. KMB's stock price was $98.15 at the time of the report.
How this was made
The 30-second read
Why it matters
The downgrade signals a bearish stance, prompting traders to reconsider exposure.
Market read
Analyst target cuts can influence short‑term price action and sector sentiment.
What to watch
Potential upside from upcoming product launches and international market expansion.
Background
Barclays updated its valuation model for Kimberly-Clark, resulting in a lower price target.
Ticker impact
Barclays lowered Kimberly-Clark price target to $105 from $115.
Potential short‑term downside pressure on KMB.
Target reduction reflects weaker outlook; traders may trim long positions.
Market effects
Consumer staples may see modest valuation adjustments as analysts reassess pricing.
U.S. market sentiment could dip slightly in the consumer staples segment.
Limited; primarily affects U.S. investors focused on Kimberly-Clark.
Counterpoint
The target cut may be overly pessimistic if recent cost‑saving initiatives materialize.
Key entities
- companyKimberly-Clark
U.S. consumer staples company (ticker KMB).
- analystBarclays
Investment bank providing the price target revision.



